Dermatomyositis Archives - Rheumatology Advisor

Immune Globulin Intravenous (Human) 10% Approved for Adult Dermatomyositis

By

July 28, 2021

The approval was based on data from the ProDERM study, which evaluated the efficacy and safety of Octagam 10% in 95 adults with dermatomyositis.

EULAR 2021 Coverage

Phase 3 Trial Shows Intravenous Immunoglobulin Therapy Safe and Effective for Adult Patients With Dermatomyositis

By

Bradley van Paridon

June 8, 2021

In a study presented at the EULAR 2021 Virtual Congress, researchers evaluated the safety and efficacy of intravenous immunoglobulin therapy in adult patients with dermatomyositis.

Inflammatory Myopathy

Case Report: Hepatosplenic T-Cell Lymphoma in Dermatomyositis Treated With Prednisolone, Azathioprine

By

Rita Aghjayan

May 6, 2021

This is the first report of hepatosplenic T-cell lymphoma in a patient with dermatomyositis treated with prednisolone and azathioprine.

Pediatric Rheumatology

Integrating Clinical and Laboratory, Biopsy Findings May Help Predict Prognosis of Juvenile Dermatomyositis

By

Sheila Jacobs

February 26, 2021

Researchers assessed clinical features, muscle biopsy scores, and myositis-specific antibody profiles in juvenile dermatomyositis, and their association with disease outcomes and treatment responses in patients.

Pediatric Rheumatology

Creatine Supplementation May Be Safe, Well Tolerated in Patients With Juvenile Dermatomyositis

By

Sheila Jacobs

February 18, 2021

Researchers aimed to evaluate the feasibility of studying creatine in juvenile dermatomyositis and to determine the effect of creatine on muscle function and metabolism.

Pediatric Rheumatology

Using Myositis-Specific Antibodies to Identify Phenotypic Subgroups of Juvenile Dermatomyositis

By

Emily Pond

January 19, 2021

Study authors investigated the link between anti-P155/140 and lipodystrophy, and between anti-P155/140 and damage to the nailfold capillary system in children with juvenile dermatomyositis.